Clinical Trial Update: A Trial Assessing Feasibility of Allostatic Load Biomarkers and CVD Risk Among Black Breast Cancer Survivors [NA]

View source ↗

Summary

This withdrawn clinical trial evaluated the feasibility of using allostatic load biomarkers to assess cardiovascular risk among Black breast cancer survivors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Cardiovascular Disease

Snippet

Sponsor: University of Florida | Conditions: Breast Cancer | NA | Status: WITHDRAWN